Today: 1 July 2026
Browse Category

NYSE:BITO 15 December 2025 - 21 January 2026

Bitcoin price breaks below $90,000 as global selloff hits crypto and traders eye the next floor

Bitcoin price breaks below $90,000 as global selloff hits crypto and traders eye the next floor

Bitcoin dropped under $90,000 for the first time since Jan. 9, hitting $88,894 by 9:27 a.m. in Singapore. The move echoed selloffs in stocks, long-term Treasuries, and Japanese bonds amid heightened volatility in debt markets. The shift is significant because the sell-off hasn't been confined to a single market. U.S. stocks experienced their sharpest one-day decline in three months on Tuesday. Bitcoin tumbled over 3% as investors dialed back risk appetite following President Donald Trump's renewed tariff threats linked to his Greenland ambitions.
21 January 2026
···
Bitcoin Price Today (Dec. 21, 2025): BTC Holds Near $88K as ETF Flows Whipsaw and 2026 Forecasts Cool

Bitcoin Price Today (Dec. 21, 2025): BTC Holds Near $88K as ETF Flows Whipsaw and 2026 Forecasts Cool

Bitcoin is ending the weekend in “wait-and-see” mode. On Sunday, December 21, 2025, BTC traded around $88,400, after moving between roughly $87,600 and $89,000 intraday—keeping the market pinned just below the psychologically important $90,000 level. Yahoo Finance That range-bound action comes after a bruising fourth quarter: Bitcoin is still about 30% below its early-October record high near $126,223, and the debate across trading desks has shifted from “how fast can BTC make new highs?” to “what finally breaks the stalemate—macro, ETF flows, or an on-chain supply squeeze?” Reuters+2Reuters+2
21 December 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 15.12.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-15-12-2025/#live”,”headline”:”Stock Market Today 15.12.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-12-15T00:00:03-05:00″,”dateModified”:”2025-12-16T00:00:02-05:00″,”coverageStartTime”:”2025-12-15T00:00:03-05:00″,”coverageEndTime”:”2025-12-16T00:00:02-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-15-12-2025/#live/u/56276063366de3fd”,”headline”:”Bitcoin ETFs fall short of 2024 inflows, but stabilize markets – Asia Morning Briefing”,”articleBody”:”Good Morning, Asia. In short: Bitcoin ETFs look less like price accelerants and more like a stabilizing force as 2024u0027s inflow record proves hard to beat. Traders now assign only a 2% chance that Bitcoin ETFs will top last yearu0027s $33.6B in net inflows, with year-to-date totals near $22.5B as of December 15. Yet the story isnu0027t stalled: last week saw ETF inflows rebound even as prices slid, suggesting
15 December 2025

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Go toTop